Jo Kilgour

PhD

Jo Kilgour is an expert Inhalation Toxicologist, having worked in the field for 30 years, initially working in the agrochemicals and chemicals sector at Central Toxicology Laboratory as a Study Director and Project Toxicologist, and for the last 20 years working almost exclusively in inhaled drug development, formerly at AstraZeneca.

Jo works with small and large Pharma companies worldwide to deliver toxicology programs for small molecules and biologics to support First in Human studies (Phase 1) through to Phase 3 clinical trials and registration. She has represented clients in interactions with Regulators in Europe and the US, and worked on drugs (small and large molecule) targeting many therapeutic areas including COPD, asthma, cystic fibrosis, idiopathic pulmonary fibrosis and anti-virals.

Jo has been an active member of the British Toxicology Society and the Association of Inhalation Toxicologists, Chairing the latter since 2011. She has co-authored a number of pivotal papers under the banner of the AIT and Industry Consortia, and has been an invited expert speaker at a number institutions and events including the US FDA, the European Chemicals Agency (EChA) and the University of Birmingham.

Charlotte Warrender

Charlotte left school straight after her GCSEs’ and joined Thor Specialities as a microbiology Laboratory Technician.  Later she joined AstraZeneca as a scientist, initially working on a wide range of histopathology techniques in the Drug Safety Department.  Studying part-time, Charlotte gained a BSc in Biomedical Science at Manchester Metropolitan University. Charlotte moved into a Facility Manager’s role whilst still working as a scientist.  The role involved scheduling programmes of work within her team, attending project meetings and ensuring capacity was available when needed.  Charlotte also managed the laboratory instrumentation and stock. Joining Gentronix as a Laboratory Technician before moving into a scientist role carrying out genetic toxicology testing, then Charlotte became a Facility Manager once again.  This role involved keeping the equipment and facility compliant to GLP regulations, whilst also being involved with the expansion of laboratories within the company,  looking after health and safety and purchasing new laboratory equipment.

Read more about Charlotte Warrender

Donna Martin

Donna worked for AstraZeneca for thirty years, working in Human Resources commenting, “Although that seems a long time, in those 30 years I’ve actually worked for three different companies.” Donna started her career in Wilmslow joining Imperial Chemical Industries (ICI) and working for Corporate Management Services (CMS). CMS later became Computer and Telecoms (CATS).  At the time of the demerger Donna moved to a Admin Team Leader role in Zeneca at the Blackley Computer Centre. During her time in Blackley she attained her Chartered Institute of Personnel and Development qualification.  After a year was offered a role back in HR but at Macclesfield at Zeneca, and subsequently moving to Alderley House on Alderley Park before eventually moving to Mereside where she has returned to. Starting as a generalist, answering general queries from a hatch, Donna specialised, following the merger with Astra, in recruitment.  Initially working as a recruitment partner, Donna went into Recruitment Standards and Processes.

Read more about Donna Martin

Heather Brown

Read more here Heather Brown

Leah Worthington

Read more here Leah Worthington

Haroon Rashid

PhD

Haroon has over 14 years of experience as a CRO study director, senior study director and toxicologist. He managed numerous investigative and regulatory toxicity studies for small molecules and biologicals in general and developmental and reproductive toxicology. He was involved in advising clients about their preclinical programmes, study design and execution, data interpretation and reporting for regulatory submission. Haroon brings his problem-solving skills and collaborative approach to the delivery of projects in an effective and timely manner.

Read more here Haroon Rashid

Isabelle Heys

Isabelle Heys is an industrial placement student from the Newcastle University studying for a BSc in Biochemistry.  They joined the Ion Channel Laboratory team and will be working on demonstrating the specific differences that exist between rodent and human seizurogenic responses.   Isabelle’s project will be focused on ion channels and a combination of bioinformatics and electrophysiological techniques.

Read more Isabelle Heys

Paul Carter

Paul has 30+ years’ experience in both CRO and pharmaceutical industries (AstraZeneca) as a study director/study monitor on a range of studies, including all delivery routes and species but specialising as an inhalation toxicologist.  For the last 10 years at AstraZeneca, Paul led the global strategic implementation of preclinical outsourcing of inhalation toxicology studies.  A recognised international expert in the field of inhalation toxicology/aerosol science, Paul has been an active committee member of the Association of Inhalation Toxicologists since 1987. Paul is a versatile toxicologist within the pharmaceutical arena and has all round knowledge of all processes involved in drug research and development.

Abigail Walker

MSc

Abigail Walker is a scientific writer with experience in toxicology, neuroscience, neurobiology and nutrition, having graduated from the University of Glasgow with a BSc and MSc in Neuroscience and from Bournemouth University with a master’s in nutrition and behaviour.  A keen communicator, she enjoys expanding her knowledge base, drawing out the key points in complex scientific subjects and working collaboratively in teams.

Joanne Wilson

Joanne has more than 20 years of experience as a DMPK scientist and project manager gained at AstraZeneca.  In this role, she led cross-functional teams to drive the optimal and efficient development of novel drugs. Joanne has worked across all therapy areas with a special expertise in oncology.  Joanne brings a blend of scientific expertise and project management skills to optimise drug discovery and development processes.

Read more here Joanne Wilson